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ARTICLE
Cryo-EM structure provides insights into the
dimer arrangement of the O-linked β-N-
acetylglucosamine transferase OGT
Richard W. Meek 1, James N. Blaza 1✉, Jil A. Busmann2, Matthew G. Alteen 3, David J. Vocadlo 2,3 &
Gideon J. Davies 1✉
The O-linked β-N-acetylglucosamine modification is a core signalling mechanism, with
erroneous patterns leading to cancer and neurodegeneration. Although thousands of proteins
are subject to this modification, only a single essential glycosyltransferase catalyses its
installation, the O-GlcNAc transferase, OGT. Previous studies have provided truncated
structures of OGT through X-ray crystallography, but the full-length protein has never been
observed. Here, we report a 5.3 Å cryo-EM model of OGT. We show OGT is a dimer,
providing a structural basis for how some X-linked intellectual disability mutations at the
interface may contribute to disease. We observe that the catalytic section of OGT abuts a
13.5 tetratricopeptide repeat unit region and find the relative positioning of these sections
deviate from the previously proposed, X-ray crystallography-based model. We also note that
OGT exhibits considerable heterogeneity in tetratricopeptide repeat units N-terminal to the
dimer interface with repercussions for how OGT binds protein ligands and partners.
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he modification of hydroxyl groups of serine and threonine
residues of proteins with O-linked β-N-acetylglucosamine
(O-GlcNAc) is implicated in transcription, translation,
signalling, proteasomal degradation and cell homeostasis1.
Incorrect patterns of O-GlcNAcylation are linked to neurode-
generation and cancers1–3. Remarkably, OGT is the sole enzyme
modifying thousands of proteins in the nucleus, cytoplasm, and
mitochondria4,5. The O-linked GlcNAc is not elongated to form
longer, complex glycans and instead cycles on and off the poly-
peptide target, more akin to phosphorylation than classical
glycosylation1. Indeed, it is suspected crosstalk occurs between
phosphorylation and O-GlcNAcylation1. Beyond glycosylation,
OGT cleaves Host Cell Factor 1 (HCF-1) and functions as an
interaction partner in large multi-protein complexes6–9.
OGT is composed of an N-terminal region comprising 13.5
tetratricopeptide repeat (TPR) units and a C-terminal multi-
domain catalytic region. The catalytic region alone can glycosylate
short peptide targets, however, the TPRs are necessary for mod-
ification of full-length proteins, promoting peptide cleavage, and
engaging in protein-protein interactions9–11. Underscoring their
importance, detrimental mutations in the TPR region are linked
to X-linked intellectual disability (XLID)2. XLID is characterised
by an inability to understand complex ideas and having limita-
tions in adaptive behaviour, which start before adulthood12.
Understanding the full-length structure of OGT, and how it
interacts with target proteins is a major goal toward ultimately
illuminating how OGT engages in protein complexes and selects
its protein substrates. In addition, identifying how full-length
OGT assembles may provide insights into how mutations con-
tribute to disease. Difficulties in obtaining a full-length structure
of OGT, however, has led to structural insights derived from only
truncated proteins, initially a dimeric 11.5 TPR-only construct
(TPR 1–11.5) and more recently the catalytic domains appended
to TPR10-13.5 (Fig. 1a, b)13,14. The former demonstrated the
TPR region generates an elongated superhelix with an internal
groove lined by an asparagine ladder10,14. These asparagine
residues are involved in the selection and binding of OGT sub-
strates by making bidentate hydrogen bonds with the peptide
backbone9. Recent work has also demonstrated aspartate residues
which line the TPR lumen which are involved in peptide
selection15,16. Originally OGT was proposed to form a trimer in
solution, but the crystal structure of the TPR 11.5 construct
suggested OGT dimerised around an interface formed at TPR
6-714. This structural observation was supported by size-exclusion
chromatography analysis, wherein disruptive mutation of resi-
dues lining the dimer interface reduced the size of the TPR 11.5
construct by roughly half14. Mutating these same residues in the
full-length protein led to a modest decrease of in vitro activity.
This reduction in activity suggests the dimer arrangement to be
important either for protein stability or supporting catalysis in the
full-length structure.
Since the current full-length model of OGT is a composite of two
independently-solved structures, in this work we determine the
structure by cryo-EM of full-length unliganded OGT to assess how
the catalytic section is oriented with respect to the full 13.5 unit TPR
region. Further, we provide an accurate understanding of the
multimeric arrangement of OGT, which should aid in exploring
how it complexes with large multi-protein partners6,17,18.
Results
Structure of full-length OGT. Through iterative cycles of particle
classification in Relion we were able to resolve substantial hetero-
geneity in the particles and determine a 5.3 Å cryo-EM map (Sup-
plementary Figs. 1–3)19. Into this map we could readily dock two
copies of the X-ray structures of the catalytic region and most of the
TPR 11.5 section (Fig. 1c, d). We find that OGT, in agreement with






























Fig. 1 The structure of unliganded OGT. ai X-ray structure of the dimeric TPRs 11.5 construct14. aii Comparison of chain A to chain B demonstrates a 40°
kink between chains. b X-ray structure of the catalytic domain of OGT appended to 4.5 TPRs, TPRs numbered13. c 5.3 Å cryo-EM map into which the cryo-
EM model of the OGT dimer was fitted (d), orange and blue represent separate chains and their associated maps depicted at 40° rotations. e Chain A of
the dimer assembly and the TPR units observed are numbered.
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relatively small interface (~560Å2), which buries <1% of the total
surface area of the full-length protein (Fig. 1).
Early maps generated during data processing provided density
into which only the catalytic domain appended to TPR units
6-13.5 could be modelled, TPR units N-terminal of the dimer
interface (TPRs 1–5) exhibited high heterogeneity, suggestive of
flexibility in the TPR units of this region. Inspired by the work
focussed on resolving structural heterogeneity in the catalytic
domain of human γ-secretase, we attempted to capture some of
the conformational states adopted by the N-terminal TPR units
by careful classification of particles20. To search the volume
around the missing N-terminal TPR repeats, a density map was
created using molmap in Chimera from the atomic coordinates of
the 11.5 TPR units crystal structure, which had been fitted into
our map and localised to the poorly resolved N-terminal region21.
This density map was used to create a mask (binary map
extension of 3 pixels and a soft edge of 12 pixels) through Relion
to search a large volume where the TPRs domains might be found
(Supplementary Fig. 3)19. The generated mask was used to
subtract signal from the regions of OGT already modelled using
the Relion particle subtraction program19. This allowed us to
perform careful clustering of the particles to identify TPR
conformations within the masked section. Interestingly, we
captured only one dominant conformation for this TPR region
into which we could further model TPRs 3-5 for one chain of the
dimer (Fig. 1e). We note that although the TPRs are flexible in
this region, which may relate to their function, the dominant state
we observed generally aligns well with the previous TPR 11.5
units crystal structure chain A (RMSD of 1.40 Å, residues
79–399)14.
Confirming the dimeric state. Previously the dimeric state of
OGT has only been inferred from size-exclusion chromatography
(SEC) using the 11.5 TPR construct14. Owing to its elongated and
non-globular shape, the wildtype 11.5 TPR construct migrates at
an estimated molecular weight of ~120 kDa while only ~70 kDa
in size14. Confirmation of the dimer assembly is realised by
mutagenesis of two residues at the dimer interface leading to
OGT migrating at ~70 kDa14. However, the large difference in
size between actual and expected migration of OGT, the very
small dimer interface, which promotes this interaction, and the
full-length OGT construct having never been analysed leads to
some ambiguity on the multimeric state of OGT in solution. To
reinforce our cryo-EM observation of OGT forming a dimeric
arrangement, the disrupting single mutants: E206A, L209A,
H212A and E215A, and the double mutant matching that pre-
viously used to assess OGT dimer state (W208A, I211A) were
produced. Owing to poor resolution at the cryo-EM model dimer
interface, it was necessary to use the 11.5 TPR crystal structure to
design these mutants (Fig. 2a). Mutants were assessed for mul-
timeric state through size-exclusion chromatography multi-angle
laser light scattering (SEC-MALLS; Fig. 2b). Wildtype, E206A,
and E215 constructs were determined to be 226, 222, and
229 kDa, respectively, all fitting a dimer model (expected mole-
cular weight, 235 kDa). The E206A and E215A mutants main-
taining the dimeric state indicate that the loss of hydrogen
bonding (E206 to H212 and E215 to W208) is tolerated in OGT
and does not play as essential role at the interface. However, a
minor peak for E215A detected at 25 min may indicate a very
small sub-population of monomeric OGT, however due to the
small quality of protein at this later peak and the tailing of the
major peak, an accurate estimate of size cannot be reliably
obtained. In contrast, the double mutant (W208A, I211A), and
the single variants L209A, and H212A are monomeric at 117, 125,
and 135 kDa, respectively (estimated monomer Mw is 117 kDa;
Fig. 2). The brute force approach of the double mutant, through
introduction of negatively charged amino acids facing one
another likely represents the true monomeric state and agrees
most strongly with the estimated monomer molecular weight.
Unexpectedly, the L209A and H212A mutants break the interface
but the earlier elution profile compared to the double mutant may
suggest transient dimer formation. These results indicate that the
hydrophobic network opposed to the polar interactions at the
interface are the primary drivers of dimerization and that the
interface provided by the TPRs is sufficient to support the
assembly.
Testing the activity of the dimer disrupting mutants. To test
whether the dimer disrupting mutants affect the catalytic activity
of OGT we conducted a series of kinetic assays using a fluorescent
activity assay for OGT22. We first evaluated the activity of wild-
type and mutant OGT towards glycosylation of a 26 amino acid
peptide substrate derived from host cell factor 1 (HCF-1) using
previously established conditions. Notably, we observed no sig-
nificant differences in the rate of glycosylation of this substrate
within the series (Fig. 3a). We hypothesised that the disruption of
the dimer interface may play a greater role in the glycosylation of
larger protein substrates that bind within the TPR lumen of OGT.
To investigate this, we therefore modified the fluorescent activity
assay to evaluate the glycosylation of recombinant TGF-beta
activated kinase 1 (TAB1) protein, a known protein substrate of
OGT23. In contrast to the shorter HCF-1 peptide substrate, using
TAB1 protein as a sugar acceptor reveals significant differences
between the glycosyl transfer catalysed by the mutants as com-
pared to wildtype OGT (Fig. 3b). Strikingly, the double mutant
shows the least activity as manifested in a relative second order
rate constant that is ~50% lower as compared to wildtype (Sup-
plementary Fig. 6). These results collectively show that mutations
affecting the dimeric state of OGT do not impact the catalytic
activity of OGT toward peptide substrates but rather influence
activity on protein substrates that engage the TPR domain of
OGT. These data also suggest that the ability of OGT to dimerise
may be an important factor governing OGT activity within cells.
Comparison of the cryo-EM model to X-ray crystallography
structures. The 11.5 TPR crystal structure forms a pseudo-
symmetric twofold dimer, with C-terminal TPR units adopting
different conformations due to a 40° bend seen in one chain
between TPR units 9 and 10 (Fig. 1aii)14. This kink was pre-
viously suggested to be due to crystal contacts causing chain B to
bend14. Notably, by cryo-EM we do not observe this 40° kink but
find that, in the absence of crystal contacts, OGT does deviate
from the previously observed 2-fold symmetry with each chain
being related to one another by a 173° rotation. This difference
arises from variation in the TPR positions at the dimer interface
that is propagated through the structure (Fig. 4a). It is unclear
whether the deviation away from a perfect 2-fold symmetry is
related to a yet undiscovered function of OGT.
Our cryo-EM generated model superimposes well onto the
catalytic region of the OGT/UDP X-ray structure (PDB: 3PE3)13,
suggesting that binding of UDP/UDP-GlcNAc causes no
conformational changes that disrupt the conformation of the
catalytic domains (Fig. 4b). Structural variations between the
cryo-EM and crystal-based models therefore exclusively relate to
the positioning of the TPR regions with respect to the catalytic
section. Crystal structures of UDP bound OGT suggest TPR 10 is
anchored to the catalytic region through bonding of E334 to
H529, whereas molecular dynamic simulations have suggested
this interaction is transient with the TPR region having the
capacity to “open” though a hinge like motion to permit active
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site access13. We note from our cryo-EM structure that TPR 10 is
shifted 5 Å further away from the catalytic domain compared to
the OGT/UDP X-ray structure (Fig. 4b, E334 Cα to H529 Cα
comparison). Since the catalytic domains superimpose well
between the OGT/UDP structure and our structure, we speculate
this conformation would also be adopted in both the UDP and
UDP-GlcNAc bound OGT structures.
The positioning of TPR 10 in the cryo-EM model widens the
gap between the TPR region and the catalytic region compared to
the previously proposed full-length model and leads to a
propagation of increasing discrepancy in the positions of the
TPR units as they extend away from the catalytic domain toward
TPR 1 and the N-terminus (Fig. 4b). The position of TPR 3, for
example, deviates by ~14 Å with respect to the catalytic region
between the composite model and the cryo-EM model, whereas
this distance for TPR 10 is only 5 Å. While we do observe some
flexibility in the TPR units, as evident from chain A and B
deviating slightly in arrangement, throughout data processing we
did not observe significantly different conformations of the TPRs
from our model, suggesting the dominant conformation of TPR
10 does not position itself closer to the catalytic region when OGT
is unliganded (Fig. 4a).
X-ray structures of OGT with a HCF-1 peptide bound to TPR





























Fig. 2 Probing the dimeric state. a The crystal structure of the 11.5 TPR construct with helices presented in expanded view depicted in darker shades.
Enlarged view with residues subject to mutagenesis depicted. Dashed lines indicate hydrogen bonding. Purple and white denote separate chains, which
form the dimer b SEC-MALLS trace demonstrating the multimeric state of OGT. Differential refractive index value depicted as a single continuous trace
across the X-axis, while molecular weight estimates shown just for the region analysed. Source data are provided as a Source Data file.
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interactions coordinating the peptide backbone9. If the OGT/
HCF-1 crystal structure is correct regarding placement of TPR
units 10-13.5, the unliganded state would need to undergo
significant conformational changes for residues to make these
same peptide interactions (Fig. 4c). In doing so, the TPR units
would move closer to the catalytic domain, limiting the accessible
space to the TPR groove. In the unliganded structure, the
immediate advantage of having a larger gap between TPR units
and the catalytic domain would be for protein substrates to have
increased access to both the TPR groove and catalytic cleft
(Fig. 5a–c). This effect is more pronounced in our structure
compared to the previously proposed composite model with the
hypothesised distance between TPR 9 and the transitional helix
being 18 Å in the composite model, and 25 Å in the cryo-EM
model (Fig. 5a–c).
In addition, to increasing access to the TPR lumen, the position
of TPR 10 in conjunction with the dimeric state of OGT may
allow us to infer and model how OGT mutations cause disease.
For instance, an XLID causing mutation (L254F) in the TPR
region has been demonstrated to distort the TPR superhelix24.
Comparing the L254F dimer arrangement to our cryo-EM model,
it is evident that this mutation also causes severe perturbation to
the dimer assembly (Fig. 5d), suggesting a mechanism by which
such mutations may contribute to disease is by altering
interactions of OGT with some of its many partners or substrates.
Our model does not provide further mechanistic insights into
how other TPR localised XLID mutations (A259T, R284P, A319T
and E339G) contribute to disease since structures for these
mutants are not available. Prior work, using the 11.5 TPR
construct has suggested that all XLID TPR mutants are dimeric in
solution, but it may be possible that the dimeric state is altered for
these mutants as we suggest may be the case for L254F here25.
Discussion
As of early 2021, the OGT field has been greatly aided by the
release of 35 structures of the catalytic domain of OGT bound to
a myriad of substrates, peptides, and inhibitors. This has enabled
careful dissection of catalysis in the active site. In general, our
model reaffirms observations previously noted, including a tight
match to the catalytic domain OGT, and adopting a dimeric
assembly supported by a relatively small interface14. We note that
without crystal formation, TPR units N-terminal of the dimer
interface exhibit considerably conformational heterogeneity and
could only be partly resolved by particle subtraction, hinting
that flexibility in this section may play a role in how OGT selects
larger substrates. Indeed loss of asparagine residues in the TPR
3-6 segment leads to decreases in glycosylation16. Major differ-
ences in our model relate to how the TPR units position them-
selves in respect to the catalytic region. Explaining the variations
in our observations from the crystal structures of OGT with UDP,
UDP-GlcNAc, and UDP-5SGlcNAc (PDBs: 3PE3, 4GZ5 and
4GZ6, respectively), we note these were all solved in the same
space group (SG) and pack with two further copies of OGT that
likely cause compression of TPR 10 towards the catalytic
domain13,26. Indeed, crystal packing and space group appear to
be the primary drivers of the TPR conformations seen in crystal
structures (Fig. 6a). For example, in the OGT/UDP-5SGlcNAc/
LaminB1 peptide ternary complex (SG: F222) the peptide does
not interact with the TPRs yet a 6 Å shift in TPR 10 is seen as
compared to the OGT/UDP structure (SG: P321), suggesting the
altered position is attributable to different space-groups
(Fig. 6b)13,27. In agreement, the OGT/UDP/gTAB1 ternary pep-
tide structure (SG: P321) shows the peptide extending into the
TPR units yet no change occurs in TPR 10 as compared to the
OGT/UDP structure (SG: P321), again suggesting that position-
ing of TPR 10 is a result of crystal packing rather than ligand
binding (Fig. 6b)28.
In summary, previous studies have used the superimposition of
the X-ray derived models of the TPR 11.5 construct onto the TPR
4.5 construct to represent full-length OGT protein. We here
demonstrate, however, that this superimposition model is unli-
kely to represent the dominant conformational state. In addition,
we illuminate a dimeric assembly unfettered by crystal contacts
that suggests XLID causing mutations in the TPR region cause
distortion of this dimeric conformation. We further show the
importance of the dimeric state of OGT for glycosylation of a
protein substrate using kinetic assays. This work represents the
first study of OGT by cryo-EM, and we expect further work in























































































Fig. 3 Transferase activity of the dimer disrupting mutants. a OGT wildtype and mutants were tested for their catalytic activity against HCF-1 peptide
using 3 µM BODIPY-UDP-GlcNAc, 10 µMHCF-1 peptide, and 20 nM OGT. b OGT wildtype and mutants were tested for their catalytic activity against TAB1
protein in the presence of 10 µM BODIPY-UDP-GlcNAc, 0.6 µM TAB1, and 100 nM OGT. Measurements were performed in quadruplicate and yielded
similar data in two biological replicates. Error bars represent one standard deviation (SD) from the mean. *P= 0.0101, ***P= 0.0005; two-tailed t-tests.
Source data are provided as a Source Data file.
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and co-ordinate interactions with both protein partners and
substrates.
Methods
Expression and purification of OGT for cryo-EM analysis. Full-length OGT
cDNA (isoform 1, UNIPROT identifier: O15294-3) in a pET28a plasmid with
N-terminal 6xHis-tag and thrombin cleavage site was transformed into BL21-
Gold(DE3) Escherichia coli cells for expression. Residue numbering follows the
sequence register of isoform 1 and thus the convention used for the
OGT4.5 structures. ID mutants follow the isoform 3 numbering system and are 10
amino acids out of register with our structure. These cells were grown in 4 l of
Terrific Broth (TB) to an OD600 of 1.8–2.0 before being cooled at 4 °C for 30 min.
Cultures were then induced with 0.2 mM IPTG and incubated in a shaking incu-
bator at 16 °C overnight. Cells were collected by centrifugation at 5400 × g for
20 min. The cell pellet was resuspended in 100 ml of buffer A (50 mM HEPES 7.4,
500 mM NaCl, 20 mM imidazole, 1 mM DTT) supplemented with 1 mM AEBSF,
DNAse 1 and lysozyme. Lysis of cells was by cell disruptor before clarification by
centrifugation at 41,700 × g for 1 h. Lysate was passed over 2 × 1 ml HisTrap FF
columns (GE Healthcare) equilibrated in buffer A. Protein was eluted by a stepwise
gradient of buffer B (50 mM HEPES pH 7.5, 500 mM NaCl, 250 mM imidazole,
1 mM DTT) in buffer A. Fractions containing protein were dialysed against 1 l of
25 mM HEPES 7.4. 150 mM NaCl and 1 mM DTT overnight at 4 °C. Protein
precipitate was removed by centrifugation before protein was concentrated to 2 ml
using a 10,000 MWCO Vivaspin® spin-concentrator (Sartorius). The concentrated
sample was size excluded on a 16/60 Superdex 200 column (GE Healthcare) in
25 mM HEPES pH 7.5, 150 mM NaCl and 1 mM DTT. Clean fractions of protein
were concentrated to 1.2 mg/ml and snap frozen.
Expression and purification of OGT for SEC-MALLS analysis. To improve on
protein yield, codon optimised full-length OGT DNA (isoform 3, UNIPROT
identifier: O15294-1, insertion of 10 amino acids between positions 13–22 com-
pared to isoform 1) was inserted into a pET28a vector with C-terminal 6xHis-tag.
Mutants were produced through standard site-directed mutagenesis protocols.



















Fig. 4 Comparison of cryo-EM model to crystal structures. a Superimposition of chain A (blue) onto chain B (orange) of the 5.3 Å structure demonstrates
the distortion of the twofold symmetry. bi Comparison of the cryo-EM model (chain A, blue) to the OGT/UDP X-ray structure with the TPR 11.5 X-ray
structure (chain A) superimposed (PDB: 3PE3, yellow. PDB: 1W3B, pink). Residues 544–1028 were used for superimposition. bii TPRs 9–11 and their
relative position to residues 505–538 of catalytic region. Residues suggested to promote TPR 10 anchoring to the catalytic region depicted in orange.
biii Cryo-EM map into which the TPRs and residues 505–538 were modelled. c Comparison of cryo-EM model (chain A) to the OGT/UDP/HCF-1 peptide
ternary complex (PDB: 4N3C, green)9. Residues 544–1028 were superimposed. Hydrogen bonding interactions depicted as dashed orange lines.
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Expression and His-tag purification steps were as described above except only 2 l of
TB was required for each mutant. Instead of dialysis, protein was diluted to 50 mM
NaCl with 20 mM HEPES 7.5 and loaded onto a 5 ml Q Sepharose FF column pre-
equilibrated in buffer C (25 mM HEPES 7.5, 50 mM NaCl and 1 mM DTT).
Protein was eluted by a stepwise gradient of buffer D (25 mM HEPES 7.5, 1 M
NaCl and 1 mM DTT) in buffer C. Fractions containing pure protein were pooled
and concentrated to 2 ml using 10,000 MWCO Vivaspin® spin-concentrators
(Sartorius), before being size excluded on a 16/60 Superdex 200 column (GE
Healthcare) in 25 mM HEPES pH 7.5, 150 mM NaCl and 1 mM DTT. Protein was
concentrated to 3 mg/ml and snap frozen.
Cryo-EM sample preparation and data collection. For cryo-grid preparation,
OGT was diluted in 25 mM HEPES pH 7.5, 150 mM NaCl and 1 mM DTT to
1 mg/ml and supplemented with 0.5% glycerol. The cryo-EM specimen was
prepared using a FEI Vitrobot mark IV set at 100% humidity with a blot time
of 4 secs and blot force of -10 arbitrary units. A 2 µl aliquot of OGT was
applied to a UltrAuFoil R1.2/1.3 300 mesh gold grid that had been glow-
discharged for 3 min at 20 mAmp/0.38 mBar using the ambient atmosphere.
The grid was then blotted and plunge-frozen in liquid ethane. Cryo-EM images
were acquired on a Gatan K3 detector in super-resolution mode using a 300 kV
FEI Titan Krios microscope at the Electron Bio-Imaging Centre, UK. EPU
(Thermo Fisher Scientific) was used to automate data collection. Fifty movie
frames were collected at a nominal magnification of x130,000 (which creates a
calibrated super-resolution pixel size of 0.3225 Å). The dose was 1.04 e/ Å2 per
frame with a total accumulated dose of 52 e/ Å2. A 100-micron objective
aperture was used. Defocus of micrographs ranged from -1.8 microns to -3.2










Fig. 5 Deviations from proposed full-length models of OGTs. a Cryo-EM model of OGT with the measured distance between V229 Cα to E488 Cα
depicted as a pink dashed line. b Crystal structure composite model of OGT generated by superimposition of residues 313–400 of 11.5 TPR chain A
(PDB: 1W3B) onto the OGT/UDP structure (PDB: 3PE3)13, 14. Distance between V299 Cα to E488 Cα depicted as a yellow dashed line, calculated as 25 Å
for a and 18 Å for b. c Superimposition of residues 544–1028 of the Cryo-EM model onto the speculated model. A large face is opened in our structure
compared to the composite structure. d Superimposition of chain A of the L254F composite model onto chain A of our cryo-EM structure24. Composite
model was generated by superimposing our catalytic domain, with the correct TPR 10 position, onto the 11.5 TPR L254F mutant dimer crystal structure
(PDB: 6EOU) using residues 260–36024. A movement of 20 Å would be required in chain B for equivalent T771 Cα atoms to overlay.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-26796-6 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:6508 | https://doi.org/10.1038/s41467-021-26796-6 | www.nature.com/naturecommunications 7
Micrograph correction and auto-picking procedures. We used MotionCor2
within Relion-3.0.5 for frame motion correction and CTFFIND-4.1 for estimating
the contrast transfer function parameters19,29,30. A subset of 99 micrographs were
picked from using the Laplacian-of-Gaussian (LoG)-based auto-picking procedure
in Relion-3.0.519. Picked particles were used to generate 2D class templates for
subsequent particle picking from all micrographs. All templates were low pass
filtered at 20 Å to prevent the introduction of bias.
Data processing and generation of maps. Auto-picked particles (4.32 × 106
particles) were 2D classified through Relion-3.0.5, after discarding poor particles
the total number of particles was reduced to 1.53 × 106.19 Evidently some 2D
classes appeared to represent the hypothesised dimeric structure of OGT, however
due to the elongated shape of OGT we were unsure if some of the smaller classes
were OGT or noise (Supplementary Fig. 1). We decided to take a cautious
approach of including these particles in downstream steps and using 3D classifi-
cation steps to remove poor particles. Owing to the large number of particles and
the associated computation time, we were required to do this in several smaller
steps. Initially we extracted the particles downsampled to 5.208 Å and used an
angular sampling of 7.5°, this removed the bulk of the poor particles (Supple-
mentary Fig. 2). We then performed a series of further 3D classification jobs,
incrementally reducing both the pixel size and the angular sampling (Supple-
mentary Fig. 2). This reduced the number of particles to 534,051. Throughout these
classifications, one class was dominant with other particles falling into either noise
or poorly resolved forms of this dominant class (Supplementary Fig. 2). At map
threshold levels where density of the catalytic domain helices remained distinct
from one another, it was impossible to observe the TPRs N-terminal of the dimer
interface, likely because of significant structural heterogeneity in this region.
Reducing the viewing threshold of the map to near that where background noise is
visible did yield some density indicative of the missing N-terminal TPR repeats.
Initially we tried to obtain density for these TPR repeats by limiting the resolution
E-step to 8 Å during 3D classification to prevent overfitting. In doing so, one of the
four classes displayed improved density for the N-terminal TPRs (Supplementary
Fig. 3). We also tried increasing resolution by refining the CTF of the particles and
performing Bayesian polishing through Relion, however no increase in resolution
was obtained19. Particles with signal subtraction (see Results) were 3D classified
into four classes with particle alignment based on a previously refined structure.
Only one class (74102 of 329,567 particles) provided traceable density and this
density correlated well to the expected shape of the N-terminal TPR region
(Supplementary Fig. 3). From this single class, the subtracted particles were
reverted to their non-subtracted form from this single class and refined. Following
post-processing, a 5.3 Å map was generated (Fourier shell correlation (FSC) cutoff
TPR10
PDB:3PE3, SG: P321
PDB: 3PE4, SG: I121
PDB: 5NPR, SG: F222
PDB: 4N39, SG: P3221
PDB: 5VIE, SG: C2221







Fig. 6 Crystal packing changes the conformation adopted by TPR10. a Superimposition of OGT structures (polypeptide backbone only) onto OGT/UDP
(PDB: 3PE3, left) and the position adopted in TPR10 of proteins within the space group (right)9, 13, 35–37. No difference in the catalytic regions are observed,
while TPR 10 is susceptible to crystal packing due to a high degree of flexibility. b In the OGT/UDP-5SGlcNAc/LaminB1 peptide ternary complex (SG: F222,
PDB: 5BNW, blue) the peptide (purple) does not interact with the TPRs, however, TPR 10 is shifted in relation to OGT/UDP structure (SG: P321, pink)27.
The OGT/UDP/gTAB1 ternary peptide structure (SG: P321, PDB: 4AY5, green) shows the peptide (purple) extending into TPR units and TPR 10 is identical
compared to the OGT/UDP structure (SG: P321, pink)28.
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of 0.143)31 with good connectivity for almost the full polypeptide in one chain of
the dimers. Into this density it is possible to trace the full catalytic domain and
TPRs 3-13.5, albeit at low resolution in the most N-terminal segments (Supple-
mentary Fig. 4).
Modelling OGT. A composite model of full-length OGT was produced by
superimposing overlapping residues of OGT/UDP (PDB: 3PE3)13 and the TPR
11.5 (PDB: 1W3B, chain A)14. Using Chimera’s “fit in map” function we positioned
two copies of the OGT/UDP structure (PDB: 3PE3) into the density map before
using these as superimposable templates to fit the full-length structure using
“matchmaker”21. This was necessary to overcome the bias introduced by the
incorrect conformation of the TPRs when attempting to fit the full-length structure
into the map. To correct the conformation of the TPR repeats, iterative cycles of
Flex-EM and manual adjustment in Coot were undertaken32,33. Final refinements
were carried out in Phenix with rigid body restraints34. The resolution was too poor
to observe correct side chain rotameric states (although these were used in rigid
body refinement), thus we have submitted our model without sidechains. Figures
were produced using Chimera and ChimeraX21.
Size-exclusion chromatography multi-angle laser light scattering (SEC-
MALLS). SEC-MALLS analysis was conducted on a system comprising a Wyatt
HELEOS-II multi-angle light scattering detector and a Wyatt rEX refractive
index detector linked to a Shimadzu HPLC system (SPD-20A UV detector,
LC20-AD isocratic pump system, DGU-20A3 degasser and SIL-20A auto-
sampler). Experiments were conducted at room temperature. A Superdex S200
10/300 GL column pre-equilibrated in running buffer (20 mM HEPES 7.5,
200 mM NaCl) was used for separation. Sample injection was 100 µl of 3 mg/ml
OGT. Flow rate was set at 0.5 ml/min. Shimadzu LabSolutions software was used
to control the HPLC and Astra 7 software for the HELEOS-II and rEX detectors.
The Astra data collection was 1 min shorter than the LC solutions run to
maintain synchronisation. Data were analysed using the Astra 7 software and
figures created using GraphPad Prism 5. MWs were estimated using the Zimm
fit method with degree 1. A value of 0.182 was used for protein refractive index
increment (dn/dc).
OGT enzymatic activity assays. Enzyme kinetics were performed using a pre-
viously described fluorescent OGT activity assay with minor modifications22. All
assays were carried out in black Nunc 384-well plates (262260, Thermo Fisher
Scientific). For measuring glycosyl transfer to HCF-1 peptide, 20 nM OGT
wildtype and mutants were incubated in the presence of 10 µM biotinylated host
cell factor 1 (HCF-1) peptide (Biotin-VRVCSNPPCS*THETGTTNTATTATSN,
Biomatik) and 3 µM BODIPY-UDP-GlcNAc in PBS containing 0.02% triton x-
100, 12.5 mM MgCl2 and 1 mM DTT. The assay was incubated for 40 min at
ambient temperature as the reaction rate was linear during this time frame for
both HCF-1 and TAB1 assays (Supplementary Fig. 7). The reaction was ter-
minated by addition of 10 mM UDP in PBS with 0.02% triton containing
0.17 mg/ml streptavidin-coated magnetic beads (M-1002, NanoLink, Vector
Laboratories). To wash away non-transferred BODIPY-UDP-GlcNAc, the plate
wells were washed using a BioTek EL406 plate washer containing a magnetic
adapter and a BioTek 384 F magnet that allows for immobilization of HCF-1 -
bead complexes (12 wash cycles). The fluorescence signal corresponding to
glycosyl transfer to HCF-1 was measured using a Biotek Neo2 plate reader at
490 nm excitation and 525 nm emission. Measuring glycosyl transfer to TGF-
beta activated kinase 1 (TAB1) protein was done in a similar fashion. TAB1
cDNA was purchased from OriGene (SC116337) and expressed with a 6xHis-tag
using a pET28a vector. OGT wildtype and mutants were incubated at 100 nM in
the presence of 0.2 to 0.6 µM his-tagged TAB1 protein and 10 µM BODIPY-
UDP-GlcNAc in PBS containing 0.01% triton x-100 and 12.5 mM MgCl2.For
immobilization of his-tagged TAB1, Nickel-NTA dynabeads (10103D, Thermo
Fisher Scientific) were used and the wells were subjected to six wash cycles using
buffer containing 50 mM Na2HPO4, 300 mM NaCl, 0.01% triton x-100 at pH 8.
Four technical repeats were performed for each condition. Background fluor-
escence was measured in wells containing 0 µM TAB1, 0 µM HCF-1, or at 0 min
incubation and was subtracted from experimental samples. Kinetic data were
analysed using GraphPad Prism 5 and 6.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The cryo-EM maps and models generated in this study have been deposited in the PDB
and EMDB databases under accession codes 7NTF and EMD-12588, respectively. Source
data are provided with this paper for Figs. 2 and 3, and Supplementary Figs. 6 and 7. Raw
cryo-EM micrographs are available from authors upon reasonable request. The PDB was
used to access some entries used for comparisons in this work including PDBs IDs:
1W3B, 3PE3, 3PE4, 4N3C, 4N39, 4AY5, 4GZ5, 4GZ6, 5NPR, 5LVV, 5VIE, 5BNW, and
6EOU. Source data are provided with this paper.
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